Latest stories on JUNS
JUPITER NEUROSCIENCES, INC. (JUNS) files 8-K
SEC 8-K50 · neutralgeneral
JUPITER NEUROSCIENCES, INC. (JUNS) files 8-K
SEC 8-K50 · neutralgeneral
Jupiter raises CCLA synergy target as first-half profit jumps 67%
Investing.com Markets73 · bullishearnings
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
Yahoo Finance55 · neutralgeneral
JUPITER NEUROSCIENCES, INC. (JUNS) files 8-K
SEC 8-K50 · neutralgeneral
Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal
TipRanks67 · bullishm&a
Boxwood Partners Advises Expert Traffic Control on its Sale to Right Traffic
PR Newswire63 · neutralm&a
Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
Yahoo Top63 · neutralproduct/pr
Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
InvestorsHub67 · bullishproduct/pr
Jupiter Neurosciences acquires U.S. rights to ALA-002 in deal worth up to $100M
Seeking Alpha63 · neutralm&a
Risk Theory Insurance Services Launches Jupiter Platinum Home, Giving Agents a Real Answer for California's Toughest Wildfire Risks
PR Newswire58 · neutralproduct/pr
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson | JUNS Stock News
StockTitan56 · neutralgeneral
Jupiter Neurosciences Adds Economist Philipson to Board
TipRanks56 · neutralgeneral
JUPITER NEUROSCIENCES, INC. (JUNS) files 8-K
SEC 8-K50 · neutralgeneral
Jupiter Neurosciences Announces Board Member Resignation and Vacancy
TipRanks50 · neutralgeneral
JUPITER NEUROSCIENCES, INC. (JUNS) files 8-K
SEC 8-K50 · neutralgeneral
Project Jupiter Expands Community Outreach Effort Highlighting Benefits and Impacts of its Investments in New Mexico
PR Newswire58 · neutralgeneral
Jupiter Neurosciences Promotes Silva to COO and President
TipRanks55 · neutralgeneral
JUPITER NEUROSCIENCES, INC. (JUNS) files 8-K
SEC 8-K50 · neutralgeneral
Trian Affiliate launches tender offer for Janus Henderson notes
Seeking Alpha54 · neutralgeneral
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease | JUNS Stock News
StockTitan63 · neutralproduct/pr
Polymarket Taps Jupiter Exec to Lead Japan Push: Report
Yahoo Top57 · neutralgeneral